News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
227 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (271)
2 (256)
3 (204)
4 (247)
5 (146)
6 (8)
7 (6)
8 (213)
9 (225)
10 (220)
11 (227)
12 (147)
13 (21)
14 (9)
15 (248)
16 (263)
17 (190)
18 (210)
19 (103)
20 (3)
21 (7)
22 (262)
23 (241)
24 (210)
25 (179)
26 (144)
27 (3)
28 (6)
29 (213)
30 (253)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Deals
Novo Nordisk Snaps Up Corvidia Therapeutics in Deal Worth Up to $2.1 Billion
Under terms of the deal, Novo Nordisk paid $725 million upfront to Sofinnova for the Waltham, Mass.-based Corvidia, a company focused on the development of transformational therapies for cardio-renal diseases.
June 11, 2020
·
2 min read
·
Alex Keown
Drug Development
Moderna Set to Test COVID-19 Vaccine in 30,000 People Starting in July
The primary endpoint of the trial will be prevention of symptomatic COVID-19 disease, with key secondary endpoints including prevention of severe COVID-19, defined as hospitalization, and prevention of infection by SARS-CoV-2.
June 11, 2020
·
3 min read
·
Mark Terry
Drug Development
Research Roundup: Antihistamines Might Slow Down Huntington’s and More
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
June 11, 2020
·
5 min read
·
Mark Terry
Drug Development
Biopharma Update on the Novel Coronavirus: June 12
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 12, 2020.
June 11, 2020
·
4 min read
·
BioSpace Editorial Staff
Biopharmaceuticals Manufacturing Consumables Testing Market Competitive Landscape Report
The report details an exhaustive account of the global biopharmaceuticals manufacturing consumables testing market along with numerous associated factors.
June 11, 2020
·
4 min read
Laboratory Isolators Market Key Trends and Growth Drivers Detailed Analysis to 2025
Addressing the need for cost-effective, safe, and convenient methods of handling sterile compounding as well as in the preparation of cytostatic and cytotoxic materials, several market players are focusing on expanding their product ranges.
June 11, 2020
·
6 min read
Chronic Kidney Disease (CKD) Drugs Market: Rising Geriatric Population to Drive Demand
The global chronic kidney disease drugs is predicted in a report by Transparency Market Research finds intense competition and high fragmentation owing to presence of strong players in the market.
June 11, 2020
·
3 min read
Prescription Dermatology Therapeutics Market: Psoriasis drugs segment dominated the global market
The global prescription dermatology therapeutics market is expected to register a robust growth in the near future, due to growing incidences of infectious dermatological disorders and chronic illnesses.
June 11, 2020
·
4 min read
BioMidwest
Relief Therapeutics and NeuroRx Expand Clinical Trial Evaluating RLF-100 in Critically Ill COVID-19 Patients with Respiratory Failure to Houston Methodist Hospital
RELIEF THERAPEUTICS Holding AG “Relief” and its U.S. partner, NeuroRx, Inc. announced that Houston Methodist Hospital is participating in their Phase 2 clinical trial evaluating RLF-100 as a research intervention for critically ill patients with COVID-19 and respiratory failure.
June 11, 2020
·
7 min read
Business
Juvenescence Appointment of CEO for Souvien & Epigenetic Division
Juvenescence Limited, a life sciences company focused on modifying aging and increasing human healthspan, is pleased to announce the appointment of Dr. Ellen Donnelly to its Senior Leadership Team.
June 11, 2020
·
2 min read
Previous
2 of 23
Next